BHCM
CHE icon

Brevan Howard Capital Management’s Chemed CHE Stock Holding History

Brevan Howard Capital Management’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.51M Buy
5,391
+2,137
+66% +$898K 0.02% 622
2026
Q1 		$1.23M Sell
3,254
-3,485
-52% -$1.49M 0.01% 798
2025
Q4 		$2.88M Buy
6,739
+4,818
+251% +$2.1M 0.03% 367
2025
Q3 		$860K Sell
1,921
-7,573
-80% -$3.43M ﹤0.01% 976
2025
Q2 		$4.62M Buy
9,494
+7,944
+513% +$4.53M 0.03% 389
2025
Q1 		$954K Sell
1,550
-1,218
-44% -$692K 0.01% 518
2024
Q4 		$1.47M Sell
2,768
-286
-9% -$161K 0.01% 347
2024
Q3 		$1.84M Buy
3,054
+2,125
+229% +$1.2M 0.01% 300
2024
Q2 		$504K Buy
929
+461
+99% +$264K ﹤0.01% 603
2024
Q1 		$300K Sell
468
-162
-26% -$98.4K ﹤0.01% 654
2023
Q4 		$368K Buy
+630
New +$353K ﹤0.01% 626

Other funds holding CHE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Brevan Howard Capital Management's CHE Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Chemed (CHE) stake by 66% in Q2 2026, buying an estimated $898K and bringing the position to 5,391 shares worth $2.51M. The position accounts for 0.02% of the portfolio, ranked #622.

Brevan Howard Capital Management first reported a position in CHE in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.62M in Q2 2025. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Brevan Howard Capital Management held 5,391 shares of Chemed worth $2.51M as of Q2 2026.
  • Brevan Howard Capital Management bought 2,137 Chemed shares in Q2 2026, an estimated $898K.
  • Chemed made up 0.02% of Brevan Howard Capital Management's portfolio in Q2 2026, its #622 holding.
  • Brevan Howard Capital Management first reported a position in Chemed in Q4 2023 and has held it in 11 quarters since.
  • Brevan Howard Capital Management's Chemed position peaked at $4.62M in Q2 2025.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.